BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3050001)

  • 1. Polysaccharide-protein conjugate vaccines for the prevention of Haemophilus influenzae type b disease.
    Weinberg GA; Granoff DM
    J Pediatr; 1988 Oct; 113(4):621-31. PubMed ID: 3050001
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatrics academy issues recommendations on use of Haemophilus influenzae type b conjugate vaccine.
    Clin Pharm; 1988 Sep; 7(9):634. PubMed ID: 3266482
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in vaccinated children who developed Haemophilus disease.
    Weinberg GA; Murphy TV; Granoff DM
    Pediatrics; 1990 Oct; 86(4):617-20. PubMed ID: 2216629
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of Haemophilus influenzae type b disease: vaccines and passive prophylaxis.
    Wenger JD; Ward JI; Broome CV
    Curr Clin Top Infect Dis; 1989; 10():306-39. PubMed ID: 2679698
    [No Abstract]   [Full Text] [Related]  

  • 5. Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children.
    Eskola J; Takala AK; Käyhty H
    Curr Opin Pediatr; 1993 Feb; 5(1):55-9. PubMed ID: 8374627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children with conditions associated with impaired antibody responses to type b polysaccharide vaccine.
    Weinberg GA; Granoff DM
    Pediatrics; 1990 Apr; 85(4 Pt 2):654-61. PubMed ID: 2179856
    [No Abstract]   [Full Text] [Related]  

  • 7. Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older. Recommendations of the immunization practices advisory committee (ACIP).
    MMWR Recomm Rep; 1991 Jan; 40(RR-1):1-7. PubMed ID: 1899280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finnish efficacy trials with Haemophilus influenzae type b vaccines.
    Eskola J; Peltola H; Käyhty H; Takala AK; Mäkelä PH
    J Infect Dis; 1992 Jun; 165 Suppl 1():S137-8. PubMed ID: 1588148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary: results of efficacy trials in Alaska and Finland of Haemophilus influenzae type b conjugate vaccine.
    Ward J
    Pediatrics; 1990 Apr; 85(4 Pt 2):667. PubMed ID: 2179858
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines.
    Madore DV; Phipps DC; Eby R; Johnson CL; Smith DH
    Contrib Microbiol Immunol; 1989; 10():125-50. PubMed ID: 2684505
    [No Abstract]   [Full Text] [Related]  

  • 11. Conjugated Haemophilus influenzae type b vaccine.
    Med Lett Drugs Ther; 1988 Apr; 30(764):47-8. PubMed ID: 3258400
    [No Abstract]   [Full Text] [Related]  

  • 12. Responses of children to booster immunization with their primary conjugate Haemophilus influenzae type B vaccine or with polyribosylribitol phosphate conjugated with diphtheria toxoid.
    Decker MD; Edwards KM; Bradley R; Palmer P
    J Pediatr; 1993 Mar; 122(3):410-3. PubMed ID: 8441096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of young infants with sickle cell disease with a Haemophilus influenzae type b saccharide-diphtheria CRM197 protein conjugate vaccine.
    Gigliotti F; Feldman S; Wang WC; Day SW; Brunson G
    J Pediatr; 1989 Jun; 114(6):1006-10. PubMed ID: 2786061
    [No Abstract]   [Full Text] [Related]  

  • 14. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccine.
    Pediatrics; 1988 Jun; 81(6):908-11. PubMed ID: 3259309
    [No Abstract]   [Full Text] [Related]  

  • 15. New vaccines against Haemophilus influenzae type b.
    Shapiro ED
    Pediatr Clin North Am; 1990 Jun; 37(3):567-83. PubMed ID: 2190140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
    Sood SK; Daum RS
    Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the Haemophilus influenzae type b conjugate vaccine PRP-D.
    Robbins JB; Schneerson R
    N Engl J Med; 1990 Nov; 323(20):1415-6. PubMed ID: 2233910
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
    Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
    N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
    Mäkelä PH; Eskola J; Peltola H; Takala AK; Käyhty H
    Pediatrics; 1990 Apr; 85(4 Pt 2):651-3. PubMed ID: 2179855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization with recently and previously licensed vaccines.
    Pediatrics; 1993 Sep; 92(3):480-8. PubMed ID: 8361814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.